Ingen internetforbindelse — viser den gemte version af siden.

Cellectis SA

USUSD
← Til screeneren

Cellectis SA (LSE:0WA2) — Biotechnology: Pharmaceutical Preparations. Antal børser, hvor selskabets aktier handles: 3. På denne side — kurs og diagram, udbytte, største aktionærer og historik over antal aktier.

Om virksomheden

Websted
cellectis.com
Investorrelationer
cellectis.com/en/investors/governance/
Sektor
Health Care · Biotechnology: Pharmaceutical Preparations
Hovedkontor
France, France
Administrerende direktør
Dr. Andre Choulika Ph.D.
Ansatte
224
Grundlagt
1999
Børsnoteret siden
09.01.2018 (LSE:0WA2)
Udestående aktier
72.72 mio.
Free float
48.58 mio.
Markedsværdi
148.06 mio. USD
Insidere
0%
Institutionelle investorer
15.36%
Branche (SIC)
Biological Products, (No Diagnostic Substances)
Juridisk form
QVPB
ISIN
FR0010425595
LEI
5493000KKX5VQ37Q2W83
Beskrivelse

Cellectis S.A., a clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates in the field of immuno-oncology and gene therapy product candidates in other therapeutic indications. The company is developing BALLI-01, to evaluate the safety, expansion, persistence, and clinical activities of lasme-cel in patients with r/r ALL; NatHaLi-01, designed to evaluate the safety, expansion, persistence, and clinical activity of eti-cel in patients with relapsed or refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL). It also develops ALPHA3, targets Large B-Cell Lymphoma (LBCL); TRAVERSE, for the treatment of patients with advanced or metastatic clear cell renal cell carcinoma (RCC). In addition, the company Melanoma, for treatment of unresectable or metastatic melanoma. Cellectis S.A. was founded in 1999 and is headquartered in Paris, France.

Børser og tickere

BørsTickerValutaPrisType
US USA StocksCMVLF OTCUSD3.47 +12.66%almindelige aktier
LSE London Stock Exchange0WA2 IOBEUR2.65 +0.00%almindelige aktier
PA Euronext ParisALCLS primærEUR1.228 -1.60%almindelige aktier

Kurs over 3 måneder

stigningsdag faldsdag udbyttets ex-dato udbetalingsdatoHold musen over / tryk på en dag — åbnings-, luknings-, højeste og laveste kurs

Udbytte

Ingen udbyttebetalinger fundet (tjekket 07.10.2026). Virksomheden udbetaler sandsynligvis ikke udbytte.

Nyheder denne uge

Endnu ingen nyheder fra virksomhedens websted.

annonce

Største ejere

EjerAndelAktierRapportdato
B Group, Inc.4.55%3.28 mio.2026-06-30
Long Focus Capital Manag…3.8%2.74 mio.2026-06-30
UBS AM, a distinct busin…3.67%2.64 mio.2026-06-30
iShares Trust-iShares Bi…0.33%235 6962026-08-31
Nomura Asset Management…0.31%226 8752026-06-30
Delaware Group Equity Fu…0.31%226 8752026-06-30
Blackrock Inc.0.31%225 4442026-06-30
Morgan Stanley0.12%85 4552026-06-30
LPL Financial LLC0.12%84 4152026-06-30
Susquehanna Internationa…0.07%50 4532026-06-30
BNP Paribas Financial Ma…0.06%40 1002026-06-30
UBS Group AG0.05%33 9262026-06-30
Fidelity Concord Street…0%1 9492026-07-31